Posluma Approved for PET Imaging in Prostate Cancer ...Middle East

Flotufolastat fluorine-18 (Posluma), a new PSMA-targeted PET radiopharmaceutical, has been approved in the US for use in prostate cancer. Medscape Medical News

Hence then, the article about posluma approved for pet imaging in prostate cancer was published today ( Wednesday 31/05/2023 - 05:16 PM ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Posluma Approved for PET Imaging in Prostate Cancer )

Also on site :

• Five killed in helicopter crash on Africa’s highest mountain (VIDEO)
• Presidency’s General Secretariat reviews Social Insurance institution performance
• The Christmas Day Storm